INS and metabolic dysfunction-associated steatotic liver disease: Given previous research has shown blocking ceramide biosynthesis is beneficial6,9, we hypothesized that FEN could be used as a novel intervention for NAFLD/NASH and atherosclerosis, in addition to its beneficial effects of decreased adiposity and improved insulin sensitization, via prevention of excess ceramide accumulation.